Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211)
Market Open
7 Aug, 06:57
SSE SSE Primary ¥
39. 56
+1.65
+4.3524%
¥
11.3B Market Cap
- P/E Ratio
3.87% Div Yield
6.09M Volume
- Eps
¥ 37.91
Previous Close Want to track 600211 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.28 |
| | | - | 0.2 |
| | | - | 0.1 |
| | | - | 0.13 |
| | | - | 0.2 |
| | | - | 0.08 |
| | | - | 0.04 |
| | | - | - |
| | | - | 0.05 |
| | | - | 0.06 |
600211 Earnings Reports FAQ
What is the earnings per share (EPS) for 600211?
EPS data for 600211 is currently not available, as Tibet Rhodiola Pharmaceutical Holding Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 10 years, the earnings growth rate has been approximately 113.14%, reflecting the 600211's performance and SSE market conditions.
When is the next earnings release date?
Tibet Rhodiola Pharmaceutical Holding Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Tibet Rhodiola Pharmaceutical Holding Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600211 at this time, as Tibet Rhodiola Pharmaceutical Holding Co., Ltd has no recent EPS data to calculate it.
